AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 122 min read$TRNS

Gillette Christopher P. sold $47K of TRNS

Gillette Christopher P. sold 504 shares of TRANSCAT INC (TRNS) at $94.23 on 2026-08-07.

Original reporting
SEC EDGAR · Gillette Christopher P.
Published Aug 12, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TRNS
Neutral
medium confidence
Mentioned
$TRNS
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRNSNeutralLow
01

Why it matters

The newest information is the specific open-market sale size, price, and resulting holdings after the transaction.

02

Market read

Traders may note insider selling, but the disclosed transaction value is small and lacks a fundamental catalyst.

03

What to watch

No 10b5-1 plan is stated, but the article does not provide context on prior holdings, compensation, or whether other insiders sold around the same time.

Relevance 3/10Novelty 3/10Timing: filed after-hours on 2026-08-12, reflecting the 2026-08-07 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Transcat (TRNS).

Company-level read

Ticker impact

$TRNSNeutralMedium confidence
Context

Transcat director Gillette Christopher P sold 504 shares in an open-market transaction for about $47.5K, per a newly filed Form 4.

Expected impact

Low likelihood of a sustained price move; any impact is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing discloses the sale details (date, shares, price, post-transaction holdings) but provides no accompanying operational or financial catalyst.

Market effects

Sector

No clear sector read-through from a single small insider sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be unrelated to company outlook (taxes, diversification, personal liquidity), especially with only 200 shares remaining post-sale.

Key entities

  • issuer
    TRANSCAT INC

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Gillette Christopher P.

    Director who sold 504 shares at $94.2345 on 2026-08-07.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TRNS insider trading history →

Related articles

AUG 4
$TRNSMed

Transcat’s (NASDAQ:TRNS) Q2 CY2026: Strong Sales

Transcat (NASDAQ:TRNS) reported Q2 CY2026 results. Revenue rose 21.6% year on year to $92.95 million, topping Wall Street estimates by 7.4%. Non-GAAP adjusted EPS was $0.51, up 35.1% versus analysts’ consensus and down from $0.59 a year earlier. Analysts expect revenue to grow about 6% over the next 12 months.

financialcontent.com5 min
AUG 4
$TRNSMed

TRANSCAT INC (TRNS): Results of Operations and Financial Condition

TRANSCAT INC (TRNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 trns-20260804xex991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal First Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growt

SEC EDGAR 8-K7 min
MAY 27
$TRNSHighAI 9/10

Transcat Inc (TRNS) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansion

Transcat’s CEO Jaime Irick said he will apply Lean Six Sigma to improve efficiency, cycle times, customer-facing processes, and innovation. CFO Thomas Barbato noted Q4 service gross margins were pressured by new customer onboarding, expecting normalization in fiscal 2027 H1 and year-over-year margin gains for the full year. He reiterated an M&A push into new geographies, citing a Latin America SCM acquisition in Costa Rica and exploring sites in several US regions; rental is expected to grow low

finance.yahoo.com4 min
MAY 26
$TRNSHighAI 9/10

Transcat Q4 Earnings Call Highlights

Transcat (NASDAQ:TRNS) reported fiscal Q4 consolidated revenue up 16% to $89.3M and full-year revenue up 19% to $331.9M, according to management on its earnings call. Service revenue rose 18% (7% organic) and marked 68 straight quarters of YoY service growth; service gross margin was 35.5%. Adjusted Q4 EPS was $0.56; full-year adjusted EPS $1.84. Management expects higher service organic growth in fiscal Q1 vs Q4.

dailypolitical.com7 min
MAY 26
$TRNSHighAI 9/10

Full Transcript: Transcat Q4 2026 Earnings Call - Transcat (NASDAQ: TRNS)

Transcat (NASDAQ:TRNS) reported Q4 FY2026 consolidated revenue of $89.3 million, up 16%, and full-year revenue growth of 19%. Service revenue rose 18% in Q4 and 20% for the year, supporting gross profit up 18% and gross margin expansion of 50 bps. Adjusted EBITDA grew 23% for the full year. The company said its SCM Metrology acquisition expands operations into Latin America.

benzinga.com6 min